Co-administration of nobiletin and tetrahydrocurcumin enhanced the cytotoxicity to breast cancer through inhibiting CYP1A1 enzyme: from the perspective of pharmacokinetic interactions
Abstract Background & objectives: The introduction of traditional Chinese medicine to the treatment of breast cancer increases the risk of…